These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23884195)

  • 21. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.
    Ling LH; Kistler PM; Ellims AH; Iles LM; Lee G; Hughes GL; Kalman JM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2012 Dec; 60(23):2402-8. PubMed ID: 23141493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible cardiomyopathy after radiofrequency ablation of 30-year persistent atrial tachycardia.
    Suzuki A; Shiga T; Arai K; Shoda M
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24326427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causes of repeated remodeling of left ventricle after Dor procedure.
    Shipulin VM; Kazakov VA; Suhodolo IV; Krivoshekov EV; Lezhnev AA; Kozlov BN; Vaizov VCh; Miller AA
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):772-7. PubMed ID: 17884848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversibility of tachycardiomyopathy after successful radiofrequency catheter ablation: intermediate results.
    Raungratanaamporn O; Bhuripanyo K; Krittayaphong R; Sriratanasathavorn C; Raungratanaamporn S; Kangkagate C; Nademanee K; Chaithiraphan S
    J Med Assoc Thai; 2001 Feb; 84(2):258-64. PubMed ID: 11336087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global longitudinal strain and global circumferential strain by speckle-tracking echocardiography and feature-tracking cardiac magnetic resonance imaging: comparison with left ventricular ejection fraction.
    Onishi T; Saha SK; Delgado-Montero A; Ludwig DR; Onishi T; Schelbert EB; Schwartzman D; Gorcsan J
    J Am Soc Echocardiogr; 2015 May; 28(5):587-96. PubMed ID: 25577185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between left ventricular diastolic function and ejection fraction in dilated cardiomyopathy using magnetic resonance imaging with late gadolinium enhancement.
    Nanjo S; Yoshikawa K; Harada M; Inoue Y; Namiki A; Nakano H; Yamazaki J
    Circ J; 2009 Oct; 73(10):1939-44. PubMed ID: 19729860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome.
    Mountantonakis SE; Frankel DS; Gerstenfeld EP; Dixit S; Lin D; Hutchinson MD; Riley M; Bala R; Cooper J; Callans D; Garcia F; Zado ES; Marchlinski FE
    Heart Rhythm; 2011 Oct; 8(10):1608-14. PubMed ID: 21699837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of Left Ventricular Dysfunction in Patients With Tachycardia-Induced Cardiomyopathy: Impacts on Remodeling After Atrial Flutter Ablation.
    De Larochellière H; Brouillette F; Lévesque P; Dognin N; St-Germain R; Rimac G; Lemay S; Philippon F; Sénéchal M
    Am J Cardiol; 2024 Feb; 213():132-139. PubMed ID: 38114044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
    Kwon DH; Halley CM; Carrigan TP; Zysek V; Popovic ZB; Setser R; Schoenhagen P; Starling RC; Flamm SD; Desai MY
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):34-44. PubMed ID: 19356530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catheter ablation treatment of supraventricular tachycardia-induced cardiomyopathy.
    Lashus AG; Case CL; Gillette PC
    Arch Pediatr Adolesc Med; 1997 Mar; 151(3):264-6. PubMed ID: 9080934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation of incessant left atrial tachycardia without fluoroscopy in a pregnant woman.
    Ferguson JD; Helms A; Mangrum JM; DiMarco JP
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):346-9. PubMed ID: 20662991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of systolic and diastolic function after ablation of incessant supraventricular tachycardia.
    Salemi VM; Arteaga E; Mady C
    Eur J Heart Fail; 2005 Dec; 7(7):1177-9. PubMed ID: 16326364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of premature ventricular complexes induced cardiomyopathy. Influence of concomitant structural heart disease.
    Abdelhamid MA; Samir R
    Indian Heart J; 2018; 70(3):410-415. PubMed ID: 29961459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.